These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10871160)

  • 1. Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up.
    Cannavò S; Squadrito S; Finocchiaro MD; Curtò L; Almoto B; Vieni A; Trimarchi F
    Horm Metab Res; 2000 May; 32(5):190-5. PubMed ID: 10871160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
    Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
    J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of differentiated thyroid carcinoma in acromegaly.
    Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
    Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly.
    Wüster C; Steger G; Schmelzle A; Gottswinter J; Minne HW; Ziegler R
    Horm Metab Res; 1991 Mar; 23(3):131-4. PubMed ID: 1907592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center.
    Uchoa HB; Lima GA; Corrêa LL; Vidal AP; Cavallieri SA; Vaisman M; Buescu A; Gadelha MR
    Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):685-90. PubMed ID: 24402013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastosonographic evaluation of thyroid nodules in acromegaly.
    Scacchi M; Andrioli M; Carzaniga C; Vitale G; Moro M; Poggi L; Pecori Giraldi F; Fatti LM; Cavagnini F
    Eur J Endocrinol; 2009 Oct; 161(4):607-13. PubMed ID: 19666699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.
    Dogan S; Atmaca A; Dagdelen S; Erbas B; Erbas T
    Endocrine; 2014 Feb; 45(1):114-21. PubMed ID: 23670709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pituitary-thyroid axis in acromegaly.
    Eskildsen PC; Kruse A; Kirkegaard C
    Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella.
    Cannavò S; Curtò L; Venturino M; Squadrito S; Almoto B; Narbone MC; Rao R; Trimarchi F
    J Endocrinol Invest; 2002 Mar; 25(3):236-9. PubMed ID: 11936465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland.
    Kasagi K; Shimatsu A; Miyamoto S; Misaki T; Sakahara H; Konishi J
    Thyroid; 1999 Aug; 9(8):791-6. PubMed ID: 10482372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels.
    Miyakawa M; Saji M; Tsushima T; Wakai K; Shizume K
    J Clin Endocrinol Metab; 1988 Nov; 67(5):973-8. PubMed ID: 3053751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas.
    Colao A; Merola B; Ferone D; Marzullo P; Cerbone G; Longobardi S; Di Somma C; Lombardi G
    Eur J Endocrinol; 1995 Aug; 133(2):189-94. PubMed ID: 7655643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DECREASE IN ACROMEGALY-ASSOCIATED THYROID ENLARGEMENT AFTER NORMALIZATION OF IGF-1 LEVELS: A PROSPECTIVE OBSERVATION AND IN VITRO STUDY.
    Chen Z; Jiang X; Feng Y; Li X; Chen D; Mao Z; He D; Zhu Y; Wang H
    Endocr Pract; 2020 Apr; 26(4):369-377. PubMed ID: 31859554
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of disease activity on thyroid diseases in patients with acromegaly: basal evaluation and follow-up.
    Herrmann BL; Baumann H; Janssen OE; Görges R; Schmid KW; Mann K
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):225-30. PubMed ID: 15146366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children.
    Portes ES; Oliveira JH; MacCagnan P; Abucham J
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):183-9. PubMed ID: 10931099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in basal and stimulated TSH and other parameters of thyroid function in acromegaly after transsphenoidal surgery.
    Geelhoed-Duijvestijn PH; Bussemaker JK; Roelfsema F
    Acta Endocrinol (Copenh); 1989 Aug; 121(2):207-15. PubMed ID: 2505466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.
    Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalization of thyroid stimulating hormone levels in acromegalic patients after selective adenomectomy.
    Tsuchiya H; Onishi T; Mori S; Lee S; Kohno H; Imanaka S; Saitoh Y; Mogami H; Uozumi T; Kumahara Y
    Endocrinol Jpn; 1984 Dec; 31(6):687-95. PubMed ID: 6442697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
    Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.